Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease

참고문헌 (10)

1. Baumgart DC, "Inflammatory bowel disease: clinical aspects and established and evolving therapies", Lancet, 369, pp.1641~1657 (2007)
2. 한동수, "Current Status and Prospects of Intestinal Microbiome Studies", Intestinal research, 12(3), pp.178~183 (2014), 대한장연구학회
3. Fuss IJ, "Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5", J Immunol, 157, pp.1261~1270 (1996)
4. Geremia A, "Innate and adaptive immunity in inflammatory bowel disease", Autoimmun Rev, 13, pp.3~10 (2014)
5. Buisine MP, "Abnormalities in mucin gene expression in Crohn’s disease", Inflamm Bowel Dis, 5, pp.24~32 (1999)
6. 김정목, "Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases", Intestinal research, 12(1), pp.20~33 (2014), 대한장연구학회
7. MacDonald TT, "Regulation of homeostasis and inflammation in the intestine", Gastroenterology, 140, pp.1768~1775 (2011)
8. Romagnani S, "Lymphokine production by human T cells in disease states", Annu Rev Immunol, 12, pp.227~257 (1994)
9. Siegmund B, "Innate and adaptive immunity in inflammatory bowel disease", World J Gastroenterol, 17, pp.3178~3183 (2011)
10. 김미진, "Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn’s Disease with Infliximab Therapy", Gut and Liver, 9(3), pp.370~380 (2015), 거트앤리버 발행위원회

관련 논문AI추천